Dr. Craig Arthur Jeschke, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4225 Altamont Place, Suite 201, White Plains, MD 20695 Phone: 240-607-1500 Fax: 240-607-1510 |
Dr. Kimberly Destefano Larsen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4225 Altamont Pl Ste 201, White Plains, MD 20695 Phone: 240-607-1500 |
Dr. Lorie F Cram, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4225 Altamont Pl, Suite 201, White Plains, MD 20695 Phone: 240-607-1500 Fax: 410-367-2215 |
Ms. Zakiya Steadman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4225 Altamont Pl, White Plains, MD 20695 Phone: 240-607-1500 |
Dr. Kamakshi Baig, M.D Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 4255 Altamont Pl Ste 203, White Plains, MD 20695 Phone: 301-638-9505 Fax: 301-705-8831 |
Dr. Tanika Lasien Day, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4225 Altamont Pl Ste 201, White Plains, MD 20695 Phone: 240-607-1500 Fax: 240-607-1510 |
News Archive
April showers can increase the amount of mold found inside and outside the home. Along with pollens from trees, grasses, and weeds, molds are an important trigger of allergic rhinitis, affecting nearly 40 million Americans, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).
The Muscular Dystrophy Association has announced it has awarded $1.6 million to Asklepios, a biotechnology company closely allied with the University of North Carolina at Chapel Hill, to develop gene therapy strategies for Duchenne muscular dystrophy (DMD), a fatal, childhood-onset disease.
Researchers from the European Molecular Biology Laboratory in Heidelberg, Germany, and the Max-Planck Institute of Immunobiology Freiburg have identified a novel protein complex that regulates around 4000 genes in the fruit fly Drosophila and likely plays an important role in mammals, too. Published today in Molecular Cell, their findings explain how another regulatory protein can lead a double life.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).
› Verified 2 days ago